Evidence map›Paper›PMID 28674867›Full record

ArticleClinical autonomic research : official journal of the Clinical Autonomic Research Society2017

Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease.

Daniel Kremens, Mark Lew, Daniel Claassen, Brent P Goodman

Open access · hybridAbstract readCase ReportsLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Orthostatic Hypotension in Parkinson Disease.Clinics in geriatric medicine · 2020
    Review
  4. Review
  5. Orthostatic hypotension in hereditary transthyretin amyloidosis: epidemiology, diagnosis and management.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2019
    Review
  6. Review
  7. Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies.Movement disorders : official journal of the Movement Disorder Society · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Daniel KremensDepartment of Neurology, Thomas Jefferson University, Philadelphia, PA, USA.
Mark LewDepartment of Neurology, University of Southern California, Los Angeles, CA, USA. marklew@usc.edu.
Daniel ClaassenDepartment of Neurology, Vanderbilt University, Nashville, TN, USA.
Brent P GoodmanDepartment of Neurology, Mayo Clinic Arizona, Scottsdale, AZ, USA.
Mayo Clinic in Arizona · USThomas Jefferson University · USUniversity of Southern California · USVanderbilt University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antiparkinson AgentsDroxidopaDrug Therapy, CombinationFemaleFludrocortisoneHumansHypotension, OrthostaticMiddle AgedMidodrineMineralocorticoidsParkinson DiseaseVasoconstrictor AgentsAntiparkinson AgentsDroxidopaFludrocortisoneMidodrineMineralocorticoidsVasoconstrictor AgentsDroxidopaFludrocortisoneMidodrineNeurogenic orthostatic hypotensionParkinson’s disease

Identifiers

PMID28674867
PMCPMC5524861
OpenAlexW2729239830

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.